Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
136 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
3 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
4 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
5 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
6 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
7 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
8 Unknown  Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
9 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
10 Recruiting Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Condition: Coccidioidomycosis
Intervention:
11 Recruiting Optimal Fluid Management in Adult Severe Malaria
Conditions: Malaria;   Sepsis
Intervention:
12 Unknown  Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease
Conditions: Chagas Disease;   Lactation
Intervention:
13 Unknown  Human Immunity to MSP-1 in Western Kenya
Condition: Plasmodium Falciparum Malaria
Intervention:
14 Recruiting Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal Amphotericin B;   Drug: Miltefosine
15 Recruiting Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)
Conditions: Malaria;   Human Immunodeficiency Virus
Interventions: Drug: Monthly dihydroartemisinin-piperaquine (DP) for adult women during pregnancy;   Drug: Monthly dihydroartemisinin-piperaquine (DP) for infants
16 Not yet recruiting CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
Condition: Chagas Disease
Interventions: Drug: Nifurtimox;   Drug: Benznidazole
17 Unknown  A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
Conditions: Uncomplicated Falciparum Malaria;   Vivax Malaria
Interventions: Drug: Dihydroartemisinin + Piperaquine (Artekin);   Drug: artesunate-sulphadoxin/pyrimethamine, chloroquine
18 Recruiting Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
Condition: Malaria
Interventions: Biological: FMP012 with AS01B adjuvant system;   Other: P falciparum Controlled Human Malaria Infection (CHMI)
19 Recruiting Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
Condition: Malaria
Interventions: Biological: Pfs230D1M-EPA/Alhydrogel;   Biological: Pfs25M-EPA/Alhydrogel;   Drug: TWINRIX;   Drug: Menactra
20 Recruiting Defining the Micro-epidemiology and Elimination Strategy of Falciparum Malaria in Areas of Artemisinin Resistance
Condition: Plasmodium Falciparum Malaria
Intervention: Drug: malaria elimination using DP and low-dose primaquine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years